1. TMC125, a novel next generation nonnucleoside RT inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1;Andries;Antimicrob. Agents Chemother.,2004
2. First clinical results on antiretroviral activity, pharmacokinetics, and safety of TMC114, an HIV-1 protease inhibitor, in multiple PI-experienced patients, abstr. 8;Aresteh,2003
3. Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative (2′,3′-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro;Baba;Biochem. Biophys. Res. Commun.,1987
4. Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2.6-diaminopurine;Balzarini;Antimicrob. Agents Chemother.,1993
5. Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1;Balzarini;Curr. Topics Med. Chem.,2004